We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGNC icon
626
AGNC Investment
AGNC
$12.4B
$938K 0.01%
52,086
+394
+0.8% +$7.04K
CINF icon
627
Cincinnati Financial
CINF
$28.5B
$930K 0.01%
+10,823
New +$893K
WAB icon
628
Wabtec
WAB
$50.8B
$928K 0.01%
12,591
-46,842
-79% -$3.38M
JWN
629
DELISTED
Nordstrom
JWN
$927K 0.01%
20,885
-10,659
-34% -$486K
KMX icon
630
CarMax
KMX
$8.29B
$922K 0.01%
13,205
+423
+3% +$26.1K
CBIO
631
Crescent Biopharma
CBIO
$626M
$915K 0.01%
+734
New +$840K
KGC icon
632
Kinross Gold
KGC
$28.6B
$909K 0.01%
263,989
-112,843
-30% -$376K
IVZ icon
633
Invesco
IVZ
$13.3B
$908K 0.01%
47,017
+2,556
+6% +$47.8K
EQH icon
634
Equitable Holdings
EQH
$13.3B
$904K 0.01%
44,893
+10,639
+31% +$203K
DELL icon
635
Dell
DELL
$276B
$878K 0.01%
29,498
-55,874
-65% -$1.47M
CPRT icon
636
Copart
CPRT
$27.6B
$870K 0.01%
+57,420
New +$780K
FNF icon
637
Fidelity National Financial
FNF
$14B
$861K 0.01%
24,507
+3,446
+16% +$115K
KSS icon
638
Kohl's
KSS
$2.1B
$841K 0.01%
12,233
-1,404
-10% -$95.2K
FMC icon
639
FMC
FMC
$1.39B
$836K 0.01%
10,882
+1,545
+17% +$113K
SWKS icon
640
Skyworks Solutions
SWKS
$9.54B
$821K 0.01%
9,953
– –
SIVB
641
DELISTED
SVB Financial Group
SIVB
$821K 0.01%
3,690
+1,112
+43% +$259K
FNV icon
642
Franco-Nevada
FNV
$41.4B
$803K 0.01%
10,710
+6,840
+177% +$508K
URI icon
643
United Rentals
URI
$70.2B
$802K 0.01%
7,021
+453
+7% +$55.9K
GDDY icon
644
GoDaddy
GDDY
$12.8B
$798K 0.01%
10,608
-32,085
-75% -$2.26M
PHM icon
645
Pultegroup
PHM
$24.9B
$794K 0.01%
28,396
-122,403
-81% -$3.34M
CHL
646
DELISTED
China Mobile Limited
CHL
$791K 0.01%
15,510
-1,520
-9% -$79.4K
MOS icon
647
The Mosaic Company
MOS
$7.1B
$790K 0.01%
28,929
+4,445
+18% +$136K
HRB icon
648
H&R Block
HRB
$5.37B
$788K 0.01%
32,925
+5,246
+19% +$129K
AAP icon
649
Advance Auto Parts
AAP
$3.48B
$778K 0.01%
4,560
– –
VST icon
650
Vistra
VST
$53B
$778K 0.01%
29,900
– –
24 25
26
27 28

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.